Annovis Bio, Inc. (ANVS) Tezkor likvidlik koeffitsiyenti

Annovis Bio Corp (ANVS) korporativ emblemasi va logotipi

Nevrologik dori vositalari uchun klinik sinovlarning kengayishi xarajatlarning mutanosib ravishda oshishiga olib kelmoqda, bu esa Annovis Bio, Inc. (ANVS) kompaniyasini kapital xarajatlar rejimida saqlab qolmoqda. Annovis Bio, Inc. (ANVS) biznesi toksik oqsillarni bostirish vositalarini ishlab chiqish orqali keksaygan insonlarda miya degeneratsiyasiga qarshi kurashishga yo'naltirilgan. GURU.Markets platformasidagi ushbu kunlik narxlar grafigi aksiya narxini 3.62 darajasida ko'rsatmoqda, shu bilan birga, yuqori ilmiy noaniqlik va patent urushlari aksiya narxini tadqiqot natijalariga nisbatan o'ta sezgir qilmoqda.

Annovis Bio Corp (ANVS) Shoshilinch likvidlik koeffitsiyenti: 04.07.2022 - 30.10.2026 davri uchun

Annovis Bio, Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi Annovis Bio Corp|ANVS - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor kapitallashuvi Annovis Bio Corp|ANVS - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya uchun sof aktivlar Annovis Bio|ANVS - Buxgalteriya kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati annovisbio.com|ANVS - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Annovis Bio, Inc.|ANVS - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Annovis Bio|ANVS - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Annovis Bio Corp|ANVS - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi Annovis Bio|Tezkor likvidlik ko‘rsatkichi annovisbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
ANVS - Yakuniy foyda
Fundamental baholash:Annovis Bio Corp - ANVS
Annovis Bio Inc ishlab chiqargan mahsulot

Barqaror aktivlarning professional tanlovi emitentning zaxiralarni sotmasdan qisqa muddatli majburiyatlarni zudlik bilan to'lash qobiliyatini baholashdan boshlanadi. Acid-test likvidlik tahlili naqd pul va debitorlik qarzdorliklarini umumlashtiradi, bu esa Annovis Bio, Inc. (ANVS) uchun juda muhimdir, chunki Altsgeymer va Parkinson kasalliklari bo'yicha tadqiqotlarni diversifikatsiya qilish dori vositalari tijoratlashtirilishidan oldin klinik risklarni minimallashtirish uchun barqaror moliyalashtirishni talab qiladi.

Annovis Bio, Inc. (ANVS) raqobatchilari

Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti axsome.com|Tezkor likvidlik ACADIA Pharmaceuticals Inc. (ACAD)|Xenon Pharmaceuticals Inc. - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik Viking Pharma VKTX|SUPN: Shoshilinch likvidlik koeffitsiyenti|CPRX - Tezkor likvidlik|Shoshilinch likvidlik denalitherapeutics.com|HRMY (Harmony Biosciences Holdings, Inc.) - Tezkor likvidlik ko‘rsatkichi|BHVN (Biohaven Ltd) - Tezkor likvidlik|AMLX (Amylyx) - Tezkor likvidlik koeffitsiyenti|Trevi Corp (TRVI) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Praxis Precision Medicines (PRAX)|Oraliq qoplama koeffitsiyenti anavex.com|CeriBell - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti PRTA|Alector Therapeutics - Tezkor likvidlik koeffitsiyenti|ANNX: Tezkor likvidlik|OMER: Tezkor likvidlik koeffitsiyenti|NGNE - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik AC Immune SA|Shoshilinch likvidlik Voyager Therapeutics Inc VYGR|Tezkor likvidlik ko‘rsatkichi NMRA (Neumora Therapeutics Inc)|SCLX (Scilex Holding Company, Inc.) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti TVGN (Tevogen Bio Holdings)|Oraliq qoplama koeffitsiyenti Alpha Cognition Inc (ACOG)|CGTX - Tezkor likvidlik|IKT (Inhibikase Therapeutics Inc) - Shoshilinch likvidlik koeffitsiyenti|SAVA: Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Assertio|Tezkor likvidlik ko‘rsatkichi COYA|VistaGen Therapeutics Inc (VTGN) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik koeffitsiyenti OVID|Tezkor likvidlik koeffitsiyenti Acumen Pharmaceuticals Inc. (ABOS)|Tezkor likvidlik CervoMed Inc CRVO|ATHE: Shoshilinch likvidlik koeffitsiyenti|CLNN: Tezkor likvidlik ko‘rsatkichi|PEPG: Tezkor likvidlik|Jupiter Neurosciences Inc (JUNS) - Tezkor likvidlik|RLMD - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Grace Therapeutics Inc|Shoshilinch likvidlik koeffitsiyenti AIFF (Firefly Neuro)|Tezkor likvidlik koeffitsiyenti KLTO|NRSN - Shoshilinch likvidlik|Reviva Pharmaceuticals Holdings, Inc. - Tezkor likvidlik ko‘rsatkichi|Tezkor likvidlik koeffitsiyenti MetaVia Inc. MTVA|NRXS - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti HSDT (Helius Medical)|passagebio.com (PASG) - Tezkor likvidlik|Shoshilinch likvidlik Neuphoria Therapeutics (NEUP)|NERV (Minerva Neurosciences, Inc.) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti Athira Pharma Inc|Tezkor likvidlik Addex Therapeutics, Ltd. (ADXN)|alzamend.com - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik Cyclerion Therapeutics, Inc. CYCN|PTIX: Shoshilinch likvidlik koeffitsiyenti|KTTA - Tezkor likvidlik|Shoshilinch likvidlik Cortigent, Inc.|ATXI (Avenue Therapeutics, Inc) - Tezkor likvidlik ko‘rsatkichi|BCLI (BrainStorm Cell Therapeutics Inc.) - Tezkor likvidlik|CARA (Cara Therapeutics, Inc.) - Tezkor likvidlik koeffitsiyenti|chromocell.com (CHRO) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Eliem Therapeutics (ELYM)|Oraliq qoplama koeffitsiyenti intracellulartherapies.com|Longboard Pharma - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti MRNS|NKGen Biotech, Inc. - Tezkor likvidlik koeffitsiyenti|NRBO: Tezkor likvidlik|SAGE: Tezkor likvidlik koeffitsiyenti|SNPX - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Trevena, Inc|Shoshilinch likvidlik Vigil Neuro VIGL|Tezkor likvidlik ko‘rsatkichi WENA (Anew Medical)|CERE (cerevel.com) - Oraliq qoplash koeffitsiyenti